Every AI newsletter, investors ask on the investor interaction platform: Guangxi Liuzhou Pharmaceutical Co.Ltd(603368) is it of positive significance to launch China’s first open traditional Chinese medicine industry alliance chain platform “Xianzhu chain”?
Guangxi Liuzhou Pharmaceutical Co.Ltd(603368) (603368. SH) said on the investor interaction platform on January 7 that the “Xianzhu chain” can timely understand the demand for Chinese herbal medicines in the end consumer market, promote industrial cooperation, guide the company’s production and marketing decisions, and carry out Chinese herbal medicine transactions for the company in the future through the data access of Chinese herbal medicines from planting and harvesting to production, processing, sales and circulation Provide information guarantee for import and export trade. At the same time, after the implementation of unified traceability technical standards, it can realize data collection and information exchange, promote the development and application of digital traceability system for the whole industrial chain of traditional Chinese medicine, and enable the high-quality development of planting, R & D and production. It is of great significance to carry out international trade of traditional Chinese medicine, realize traceability management and promote upstream and downstream industrial cooperation in the future.
(source: Daily Economic News)
